Childhood Cancer

You are here

Home » Grants » All grants tagged with "Acute Lymphoblastic Leukemia (ALL)"

All grants tagged with "Acute Lymphoblastic Leukemia (ALL)"

Unraveling the Mechanisms of Inherited Predisposition to Childhood Leukemia
Vijay Sankaran, MD/PhD
Boston Children’s Hospital
Innovation Grants, Awarded 2024
DYRK1A inhibition sensitizes SMARCA4 mutated ALL cells to chemotherapy drugs
Ashley Paik
Loma Linda University
POST Program Grants, Awarded 2024
Incidence and grades of adverse events during treatment for pediatric acute lymphoblastic leukemia
Paul Saah
Emory University
POST Program Grants, Awarded 2024
Dual dietary and pharmacological targeting of OxPhos in T-ALL
Tanaya Kulkarni
Rutgers University
POST Program Grants, Awarded 2024
The role of pyruvate kinase as a therapeutic target in pediatric leukemia
Daniel Herranz Benito, PhD
Rutgers Cancer Institute of New Jersey
R Accelerated Award Grants, Awarded 2023
Immunoglobulin High-Throughput Sequencing for Refining Risk Stratification in Infant B-ALL
Carol Fries Simpson, MD
University of Rochester
Reach Grants, Awarded 2023
Elucidating the Roles of Aneuploidy in Down Syndrome-Associated Leukemia
Chun-Chin Chen, PhD
Boston Children’s Hospital
Young Investigator Grants, Awarded 2023
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia
Catherine Danis, PhD
University of Colorado Denver_ Anschutz Medical Campus
Young Investigator Grants, Awarded 2023
Novel Therapy for Pediatric Leukemia Patients with NUP98 Translocations
Jolanta Grembecka, PhD
The Regents of the University of Michigan
Reach Grants, Awarded 2022
Enhancing TKI Therapy in Ph-Like Leukemia
David Fruman, PhD
The Regents of the University of California, Irvine
Reach Grants, Awarded 2022

Pages

All childhood cancer types

Featured Hero

Stryder Nadeau

Stryder is just a big love bug, forever smiling even on his hardest days! When he was 2 years old, he stopped eating, and eventually stopped walking too. Doctors found his abdomen was full of tumors, and he spent a lot of time in hospitals and lab visits.
Read more »